Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Homogeneity of pathological response (PR) and histopathological growth pattern (HGP) in resected colorectal liver metastases (CRLM) are associated with favorable survival outcome after surgery.

Title: Homogeneity of pathological response (PR) and histopathological growth pattern (HGP) in resected colorectal liver metastases (CRLM) are associated with favorable survival outcome after surgery.
Authors: Baldin, Paméla; Beniuga, Gabriella; Carrasco, Javier; De Cuyper, Astrid; Sinapi, Isabelle; Hubert, Catherine; Navez, Benoît; Castella, Marie-Laure; Van Maanen, Aline; Mlecnik, Bernhard; Galon, Jerome; Jouret-Mourin, Anna; Van den Eynde, Marc; 2022 ASCO Annual Meeting I
Contributors: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie; UCL - (SLuc) Service d'hépato-gastro-entérologie; UCL - (SLuc) Service d'oncologie médicale; UCL - (SLuc) Service d'anatomie pathologique
Source: Journal of Clinical Oncology, Vol. 40, no.16_suppl, p. 3596-3596 (2022)
Publisher Information: American Society of Clinical Oncology (ASCO)
Publication Year: 2022
Collection: DIAL@USL-B (Université Saint-Louis, Bruxelles)
Subject Terms: Cancer Research; Oncology
Description: Background: Surgical resection of CRLM aims to maximize patient survival. However, recurrence rates remain high post-surgery. We previously reported the prognostic relevance of tumor regression grading (TRG) and HGP of resected CRLM. Several studies reported the association of tumoral heterogeneity with anti-cancer drug resistance and prognosis. This study aims to explore tumoral heterogeneity for TRG and HGP in patients resected for CRLM and its prognostic implication. Methods: Tumor homogeneity for PR and HGP was evaluated in 2 independent cohorts. Cohort 1 included 57 patients (159 CRLMs) resected after chemotherapy/bevacizumab (prospective BEV-ONCO trial). Cohort 2 included 221 patients (582 CRLMs) operated after preoperative treatment or not. TRG (1 to 5 according complete to no response), HGP (desmoplastic, pushing, replacement or mixed) were evaluated for each CRLM. Max-TRG (higher TRG among all the CRLM) was used to define PR. Homogenous TRG (TRG-h) and HGP (HGP-h) was defined when all CRLMs had the same TRG or HGP pattern. HGP homogeneous desmoplastic (HGP-hd) was defined when all CRLM had a desmoplastic HGP. TRG-h, HGP-h and HGP-hd were combined into a homogeneity score (H-score: 0 to 3, 1 point given for each parameter and summed-up). Overall survival (OS for both cohorts), progression-free survival (PFS for cohort 1) and time to relapse (TTR for cohort 2) were estimated using the Kaplan–Meier method and compared by log-rank tests. Cox proportional hazard models were used for univariate and multivariate analyses. Results: Patient and disease characteristics were comparable in both cohorts excepted for preoperative treatment. In cohort 1, TRG-h and HGP-h were significantly associated with a longer PFS (HR = 0.21; 95CI:0.10-0.43, p < 0.001; HR = 0.27; 95CI = 0.14-0.54, p < 0.001) and better OS (HR = 0.23; 95CI = 0.07-0.70, p = 0.010; HR = 0.32; 95CI = 0.10-0.93, p = 0.037). Interestingly, the same significant results were observed in cohort 2 for TTR (TRG-h: HR = 0.60; 95CI = 0.43-0.85, p = 0.004; ...
Document Type: conference object
Language: English
Relation: boreal:277921; http://hdl.handle.net/2078.1/277921
DOI: 10.1200/jco.2022.40.16_suppl.3596
Availability: http://hdl.handle.net/2078.1/277921; https://doi.org/10.1200/jco.2022.40.16_suppl.3596
Rights: info:eu-repo/semantics/openAccess
Accession Number: edsbas.2A2BE72C
Database: BASE